GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival

Size: px
Start display at page:

Download "GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival"

Transcription

1 GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION Page 1 Legend: BOLD = Required ^ = MLL Data Element Admin (Tab) ^Patient ID: Physician/Provider NPI: DOB: / / ^Arrival Date/Time: Race: Hispanic Ethnicity Cardiac Diagnosis: Pre-Hospital ^Means of transport to first facility: Gender: Male Female Unknown American Indian or Alaska Native Asian Asian Indian Chinese Filipino Japanese Korean Vietnamese Asian Yes No/UTD If yes, Mexican, Mexican American, Chicano/a Puerto Rican Confirmed AMI STEMI Confirmed AMI non-stemi Air Ambulance Walk-in Pre-Hospital/Arrival Patient Zip Code: Admission Date: Not admitted, transferred out another acute care facility. Black or African American White Native Hawaiian or Pacific Islander UTD Native Hawaiian Guamanian or Chamorro Samoan Other Pacific Islander Confirmed AMI STEMI/non- STEMI unspecified Coronary Artery Disease EMS Agency name/number: Run/Sequence number: Cuban Another Hispanic, Latino or Spanish Origin Unstable Angina Pre-Hospital Time Tracker ^EMS First ^Non-EMS First Medical Contact: Medical Contact: ^EMS Non-System Reason for Delay: Yes No EMS Dispatch: EMS arrive on scene: EMS depart scene: Destination Prearrival alert or notification: Method of 1st notification: ECG Transmission Phone call Radio Transfers ^Transferred from other facility? Yes No Transferring Facility: Transfer Time Tracker ^Arrival at First Transport hospital: requested: Transport Arrived Date/Time: Transfer out: Mode of transport from Air Inter-facility transport EMS outside facility Ambulance Agency name/number: ECG 1 st ECG Date/Time: / / : 1 st ECG obtained: Prior to hospital arrival

2 ^1 st ECG Non-System Reason for Delay: Yes No ^STEMI or STEMI Equivalent? Yes No ^If yes, STEMI or STEMI equivalent first noted: First ECG Subsequent ECG Arrival Symptom onset Date/Time: Patient first evaluated: ED Cath Lab ^Patient Current Dabigatran Rivaroxaban Medications Apixaban Warfarin After first hospital arrival If subsequent ECG, Date/Time of positive ECG: / / : If ED, Transfer out Date/Time: ^Aspirin within 24 hours of arrival? Yes No Contraindicated ^Antithrombotic taken in 24hrs prior to arrival? Yes No ^Positive cardiac biomarkers in the first 24 hours? Yes No ^History of Smoking? Yes No Hospitalization Reperfusion Reperfusion Candidate? Yes No If no, primary reason: No ST Elevation/LBBB MI diagnosis unclear Yes ^If yes, Dose Start Date/Time: Page 2 Chest pain resolved MI symptoms >12hrs ST elevation resolved No chest pain ^Thrombolytics? ^Documented non-system reason No or delay- Lytics? Yes No If yes, reason (check all that apply) Cardiac Arrest Intubation Patient refusal ^Primary PCI? Yes No PCI Time Tracker Cath Lab Activation: Patient Arrival to Cath Lab: Attending Arrival to Cath Lab: Team Arrival to Cath Lab: ^First PCI Date/Time: ^PCI Indication O Primary PCI for STEMI O PCI for STEMI (stable after successful full-dose lytic) ^Non-system reason for delay- PCI? Reperfusion Contraindications O Difficult vascular access O Cardiac arrest and/or need for intubation ^Reasons for not performing PCI O PCI for STEMI (unstable, >12 hr from sx onset) O Rescue PCI for STEMI (after failed full-dose lytic) O Patient delays in providing consent O Difficulty crossing the culprit lesion O Noncompressible vascular puncture(s) O Active bleeding on arrival or within 24 hours O Quality of life decision O Spontaneous reperfusion (documented by cath only) O Patient/family refusal O DNR at time of treatment decision O Prior allergic reaction to IV contrast O PCI for STEMI (stable, >12 hr from sx onset) O PCI for NSTEMI O None O Not performed O No reason documented O Thrombolytic Administered

3 Hospitalization ^Reasons for not administering lytics ^LVF Assessment % ^CABG During This Admission: ^LDL Cholesterol: Yes No mg/dl O Anatomy not suitable to primary PCI O Known bleeding diathesis O Ischemic stroke w/in 3 months except acute ischemic stroke w/in 3hrs O Recent bleeding within 4 weeks O Any prior intracranial hemorrhage O Suspected aortic dissection Discharge Page 3 Obtained: O Recent surgery/trauma O Significant close head or facial trauma within previous 3 months O Active peptic ulcer O Pregnancy O Intracranial neoplasm, AV malformation, or aneurysm O Prior allergic reaction to thrombolytics This Admission W/in the last year > 1 year ago Planned After Discharge O Severe uncontrolled hypertension O DNR at time of treatment decision O Traumatic CPR that precludes thrombolytics O Expected DTB < 90 minutes O No reason documented Discharge Date/Time: 1 - Home 2 - Hospice-Home 3 - Hospice-Healthcare Facility ^Discharge Status: 4 - Acute Care Facility 5 Other Health Care Facility 6 - Expired 7 Left Against Medical Advice/AMA 8 Not Documented or Unable to Determine (UTD) ^Comfort Measures Only Yes No ^Patient Referred to Cardiac Rehab? Yes No-Referral No-Medical Reason No-Pt No-Health Care System Reason Reason/Preference ^Smoking Cessation Counseling? Yes No ^ACEI at ^ARB at ^Aspirin at ^Clopidogrel at ^Prasugrel at

4 ^Ticagrelor at ^Ticlopidine at ^Anticoagulation at ^Beta Blocker at If yes, Class: Medication: Dose: Frequency: ^Statin at Optional Field-1 Optional Field-2 Optional Field-3 Page 4

5 Page 5

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Get With the Guidelines Stroke PMT. Quality Measure Descriptions

Get With the Guidelines Stroke PMT. Quality Measure Descriptions Get With the Guidelines Stroke PMT Quality Measure s Last Updated July 2016 Print Measure s Dysphagia Screen Stroke Education Rehabilitation Considered Time to Intravenous Thrombolytic Therapy 60 min LDL

More information

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic Objectives Treatment of ACS Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Define early invasive strategy and what patients typically receive this approach Compare/contrast the medications

More information

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : *** @ Sex 2060 : *** @ O Male O Female Race:

More information

ST Elevated Myocardial Infarction- Latest AHA recommendations

ST Elevated Myocardial Infarction- Latest AHA recommendations ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to

More information

Know the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium

Know the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium Know the Quality of our Care at Every Step Kansas City ACS Summit BI-State Cardiovascular Education Consortium Welcome to the Kansas City ACS Summit Objectives: Follow the flow and care of an ACS patient

More information

New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.1

New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.1 New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.1 A. DEMOGRAPHIC DATA *Hospital Type (1): 1=Primary 2=Comprehensive 3=Other *Hospital Code (2): *Hospital Transferred From Code (3):

More information

(auto) à If Yes, Most Recent LVEF Date 4155 : à If Yes, Most Recent LVEF 4160 :

(auto) à If Yes, Most Recent LVEF Date 4155 : à If Yes, Most Recent LVEF 4160 : A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Sex 2060 : O Male O Female Patient Zip Code

More information

Mission: Lifeline EMS Recognition : FMC to Device < 90 Minutes Worksheet

Mission: Lifeline EMS Recognition : FMC to Device < 90 Minutes Worksheet Mission: Lifeline EMS Recognition : FMC to Device < 90 Minutes Worksheet Did Pt. Receive PCI FMC to PCI < 90 Minutes Exclusions Documented Delay after hospital arrival (Refer to Page 4 in EMS Recognition

More information

Admission Date/Time : Patient Restriction 3036 C. HISTORY AND RISK FACTORS. Weight : Heart Failure : Prior PCI 4495 :

Admission Date/Time : Patient Restriction 3036 C. HISTORY AND RISK FACTORS. Weight : Heart Failure : Prior PCI 4495 : A. DEMGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) ther ID 2045 : Birth Date 2050 : Race: Sex 2060 : Male Female Patient Zip Code

More information

STEMI, Non-STEMI, Chest Pain?

STEMI, Non-STEMI, Chest Pain? Minnesota Chest Pain / Acute Coronary Syndrome Tool-Kit Patient with Chest Pain Or Potential Acute Coronary Syndrome STEMI, n-stemi, Chest Pain? Follow MN STEMI Guideline Follow MN n-stemi Guideline Follow

More information

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS: 1. Is this a CMS inpatient only procedure? Yes, admit as inpatient, proceed to # 3 No, proceed to # 2 2. Do you expect that the patient s condition will require a hospital stay that will cross two midnights

More information

Select one option. Unknown

Select one option. Unknown CASE RECORD FORM Active Form Group: Standard, STK (Stroke CM) LEGEND Patient ID: Bold Question = Required Admin Tab Ischemic Stroke Transient Ischemic Attack (< 24 hours) Final clinical diagnosis related

More information

Get With The Guidelines - Stroke and Trends in New Jersey

Get With The Guidelines - Stroke and Trends in New Jersey The Road to Recovery: Get With The Guidelines - Stroke and Trends in New Jersey Zainab Magdon-Ismail, DrPH Vice President, Quality & Systems Improvement Founders Affiliate (NJ-ME) American Heart Association

More information

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only

More information

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case September 19 th, 2013 Scott M Lilly, MD PhD Thrombolytics in 2013: Never Say Never Clinical Case 2 1 Evolution of STEMI Therapy The importance of absolute rest in bed for several days is clear James B

More information

Location of RSR Client-level Data Elements in CAREWare Updated Sept 2017

Location of RSR Client-level Data Elements in CAREWare Updated Sept 2017 Location of RSR Client-level Data Elements in CAREWare Updated Sept 2017 Demographics Required of all clients that received any core medical or support service if they are ELIGIBLE for RWHAP services.

More information

2013, American Heart Association

2013, American Heart Association 2013, American Heart Association Mission: Lifeline - Data, Reports and ACTION Registry - GWTG THE MISSION: BETTER HEART ATTACK CARE FOR YOUR COMMUNITY THE LIFELINE: THE AMERICAN HEART ASSOCIATION AND YOU

More information

County of Santa Clara Emergency Medical Services System

County of Santa Clara Emergency Medical Services System County of Santa Clara Emergency Medical Services System Reference # 803 STEMI Data Dictionary STEMI DATA DICTIORY Effective: October 28, 2013 Replaces: January 2009 Review: October 2016 Resources: Policy

More information

Daily practice of ACS management in the Gulf: Data from Gulf COAST

Daily practice of ACS management in the Gulf: Data from Gulf COAST Daily practice of ACS management in the Gulf: Data from Gulf COAST Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Head, Division of Cardiology Mubarak Alkabeer Hospital

More information

Management of Acute Myocardial Infarction

Management of Acute Myocardial Infarction Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care

More information

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 May 2011 1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 Yes b) If confirmed please provide details on the number of

More information

PATIENT S NOTES History and Physical Brain Attack Stroke

PATIENT S NOTES History and Physical Brain Attack Stroke UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES History and Physical Brain Attack Stroke 040527.01 page 1 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No Date and Time: Current inpatient

More information

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction? THEY AINT WHAT THEY USED TO BE Case

More information

RSR Crosswalk. Variable Client Race Race ID Values White 1 Black 2 Asian 3 Hawaiian / PI 4 Native American (AK native) 5

RSR Crosswalk. Variable Client Race Race ID Values White 1 Black 2 Asian 3 Hawaiian / PI 4 Native American (AK native) 5 October 2017 Purpose RSR Crosswalk This document can help you compare the data you currently collect in your data management system to the data required in the Ryan White Services Report (RSR). The Crosswalk

More information

Acute Coronary Syndrome (ACS) Initial Evaluation and Management

Acute Coronary Syndrome (ACS) Initial Evaluation and Management Acute Coronary Syndrome (ACS) Initial Evaluation and Management Symptoms of Possible ACS Chest discomfort with or without radiation to the arm(s), jaw, or epigastrium Short of breath Weakness Diaphoresis

More information

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1

More information

Data Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR

Data Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR Data Elements and Definitions with Case Studies Interpreting Your Outcomes Reports Kim Hustler, Clinical Quality Consultant, NCDR Beth Pruski, Program Manager, NCDR The following relationships exist: Beth

More information

GWTG Post-Discharge Follow-up Form

GWTG Post-Discharge Follow-up Form Bold font = Required field Patient ID: Date of Hospital Admission: / / mm / dd / yyyy Date Follow-up Completed: / / mm / dd / yyyy PATIENT LOGISTICS Method used for Patient follow-up: Chart Review Health

More information

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

GET WITH THE GUIDELINES- PAST AND FUTURE

GET WITH THE GUIDELINES- PAST AND FUTURE GET WITH THE GUIDELINES- PAST AND FUTURE Amy Graham, RN, BS, CEN, NREMT-P Director, Quality & Systems Improvement Kentucky and Southwest Ohio American Heart Association 1 DISCLOSURE SLIDE I AM THE QUALITY

More information

Institutional Outcomes Report 2012Q2 Sample Hospital

Institutional Outcomes Report 2012Q2 Sample Hospital Version 2.2 Institutional Outcomes Report 2012Q2 If User desires to publish or otherwise distribute or use, in whole or in part, any aggregate data or reports provided by ACCF, or produced in connection

More information

Mission: Lifeline Addressing the System of STEMI Care

Mission: Lifeline Addressing the System of STEMI Care Mission: Lifeline Addressing the System of STEMI Care Alice K. Jacobs, M.D. Boston University Medical Center Boston, MA, USA ACC West Virginia Chapter, April 2017 Disclosure Information FINANCIAL DISCLOSURE:

More information

2012 Core Measures. Acute Myocardial Infarction (AMI)

2012 Core Measures. Acute Myocardial Infarction (AMI) 2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

Q1 Contact Information

Q1 Contact Information Q1 Contact Information Answered: 25 Skipped: 0 ANSWER CHOICES Hospital Name of Person Completing Survey Email RESPONSES 100.00% 25 100.00% 25 100.00% 25 # HOSPITAL DATE 1 Research Medical Center 9/26/2018

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

The Muscatine Study Heart Health Survey

The Muscatine Study Heart Health Survey The Muscatine Study Heart Health Survey PARTICIPANT ID LABEL (include study ID, name, DOB, gender) Today s Date: - - (MM-DD-YYYY) Thank you for agreeing to participate in the International Childhood Cardiovascular

More information

NCDR PVI Registry (Peripheral Vascular Intervention Registry) v 2 Renal Artery Intervention Module- DRAFT ,,, Patient Restriction N683

NCDR PVI Registry (Peripheral Vascular Intervention Registry) v 2 Renal Artery Intervention Module- DRAFT ,,, Patient Restriction N683 Page 1 of 12 A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : Birth Date 2050 : Sex 2060 : O Male Race: (check all that apply) B. EPISODE

More information

Practitioner Education Course

Practitioner Education Course 2015 Practitioner Education Course ST Elevation Myocardial Infarction 2 Pathology Concept of vulnerable plaque Mild Atheroma Diagnosis IVUS OCT 3 Diagnosis This is based on : Clinical History ECG Changes.

More information

Primary Stroke Center Quality & Performance Measures

Primary Stroke Center Quality & Performance Measures Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition

More information

Treatment of ST-elevation myocardial infarction in China: Where are we?

Treatment of ST-elevation myocardial infarction in China: Where are we? Treatment of ST-elevation myocardial infarction in China: Where are we? Associate Professor, Yihong Sun, MD Peking University People s Hospital Beijing, China Disclosure conflict of Interest The Challenges

More information

Reperfusion Strategies for the STEMI Patient - PCI versus Thrombolysis

Reperfusion Strategies for the STEMI Patient - PCI versus Thrombolysis Reperfusion Strategies for the STEMI Patient - PCI versus Thrombolysis Scott Mikesell, DO, FACC, FSCAI, FSVM STEMI Program Director Cardiac Catheterization Laboratory Director St. Luke s Hospital, Duluth,

More information

Figure 4. Psychoactive Medication Quality Assurance Rating Survey (PQRS)

Figure 4. Psychoactive Medication Quality Assurance Rating Survey (PQRS) Figure 4. Psychoactive Medication Quality Assurance Rating Survey (PQRS) Person's Full Name Person's Case Number INSTRUCTIONS TO RATER: These guidelines apply to all items unless indicated otherwise. After

More information

Difficult Data Definitions and Scenario s

Difficult Data Definitions and Scenario s Difficult Data Definitions and Scenario s Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss key

More information

Patient Navigator Program: Focus MI Diplomat Hospital Metrics

Patient Navigator Program: Focus MI Diplomat Hospital Metrics Patient Navigator Program: Focus MI Diplomat Hospital Metrics Goal Statement: To reduce avoidable hospital readmissions for patients discharged with acute myocardial infarction (AMI) by supporting a culture

More information

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Dashboard and Outcomes Report with Case Studies

Dashboard and Outcomes Report with Case Studies Dashboard and Outcomes Report with Case Studies Kim Hustler Clinical Quality Consultant, American College of Cardiology The following relationships exist: Kim Hustler: No Disclosures Section F- Procedures

More information

A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Magnus Ohman MB, on behalf of the GEMINI-ACS-1 Investigators

More information

HAAD quality KPI; waiting time

HAAD quality KPI; waiting time Type: Waiting Time Indicator Indicator Number: WT001 Primary Care Appointment- Outpatient Setting Time to see a HAAD licensed family physician or member of their team (GP) Time of request (walk-in or by

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with

More information

HF Patient Management Tool July 2017

HF Patient Management Tool July 2017 Heart Failure Form Page 1 PMT FORM SELECTION HF ARRIVAL AND ADMISSION INFORMATION Patient ID: Legend: Elements in bold are required Internal Tracking ID: Physician/Provider NPI: Arrival Date and Time:

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACTIVASE (t-pa) FOR ACUTE MYOCARDIAL INFARCTION I. PURPOSE: A. To reduce the extent of myocardial infarction by lysing the clot in

More information

Identification and pre-notification using 12-Lead. Why this so important to our STEMI System

Identification and pre-notification using 12-Lead. Why this so important to our STEMI System Identification and pre-notification using 12-Lead Why this so important to our STEMI System Jim Smith, MD Great Plains Health, North Platte Chair, NE State EMS Board Medical Director, Emergency Services,

More information

Federation of State Boards of Physical Therapy Minimum Data Set Questionnaire

Federation of State Boards of Physical Therapy Minimum Data Set Questionnaire Federation of State Boards of Physical Therapy Minimum Data Set Questionnaire Purpose: Understanding the current United States Health Workforce enables Federal and State Governments and Health Professional

More information

DISCUSSION QUESTION - 1

DISCUSSION QUESTION - 1 CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure

More information

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals. OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral

More information

EMS Recognition Webinar August 24, 2017

EMS Recognition Webinar August 24, 2017 EMS Recognition Webinar August 24, 2017 Today s objectives: Provide you with some rationale regarding the importance of reducing FMC to device time Provide you with an overview of the 2017 Mission: Lifeline

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

Treatment of Acute Coronary Syndromes

Treatment of Acute Coronary Syndromes Treatment of Acute Coronary Syndromes UC SF Jeffrey Tabas, M.D. sf g h Associate Professor UCSF School of Medicine Emergency Services, San Francisco General Hospital Objectives Review the updated AHA/ACC

More information

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS PREVENTING HOSPITAL READMISSIONS IN CARDIOVASCULAR PATIENTS Christina Cortez Perry, MSN, FNP-C, CCCC Cardiology Coordinator- Corpus Christi Medical Center 1 2 LEARNING OBJECTIVES Identify the target patient

More information

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Caitlin C. Akerman, PharmD PGY2 Cardiology Resident WakeMed Health & Hospitals Raleigh,

More information

Physician Orders ADULT: PCI Post Procedure Plan

Physician Orders ADULT: PCI Post Procedure Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: PCI Post Procedure Phase, When to Initiate: Initiate Powerplan Phase Phase: Post Cath/PCI Hydration Protocol Phase,

More information

Thrombolysis, adjunctive pharmacology and interventions

Thrombolysis, adjunctive pharmacology and interventions ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation ESC Annual Congress Munich, 2012 Thrombolysis, adjunctive pharmacology and interventions

More information

ACCESS CENTER:

ACCESS CENTER: ACCESS CENTER: 1-877-367-8855 Emergency Specialty Services: BRAIN ATTACK Criteria: Stroke symptom onset time less than 6 hours Referring Emergency Department Patient Information Data: Time last known normal:

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

2018 Early Management of Acute Ischemic Stroke Guidelines Update

2018 Early Management of Acute Ischemic Stroke Guidelines Update 2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital

More information

King County EMS STEMI Patients Receiving PCI at King County Hospitals in 2012

King County EMS STEMI Patients Receiving PCI at King County Hospitals in 2012 King County EMS STEMI Patients Receiving PCI at King County Hospitals in 2012 Objective The goal of this report is to evaluate demographics, pre hospital and hospital response times and outcomes of ST

More information

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications

More information

Acute Coronary syndrome

Acute Coronary syndrome Acute Coronary syndrome 7th Annual Pharmacotherapy Conference ACS Pathophysiology rupture or erosion of a vulnerable, lipidladen, atherosclerotic coronary plaque, resulting in exposure of circulating blood

More information

AF Patient Management Tool December 2016

AF Patient Management Tool December 2016 Atrial Fibrillation Form Page 1 PMT FORM SELECTION: Atrial Fibrillation Patient ID: ARRIVAL AND ADMISSION INFORMATION Internal Tracking ID: Arrival Date and Time: Admit Date: Point of Origin for Admission

More information

NHS QIS National Measurement of Audit Acute Coronary Syndrome

NHS QIS National Measurement of Audit Acute Coronary Syndrome NHS QIS National Measurement of Audit Acute Coronary Syndrome Things have changed based on the experience and feedback from the first cycle of measurement and, for the better we think! The Acute Coronary

More information

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post

More information

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.

More information

Cardiology Cath Conference

Cardiology Cath Conference Cardiology Cath Conference David Stultz, MD Cardiology Fellow, PGY-6 February 14, 2006 Case #1 84 yo WM brought by squad this am for? syncope Pt reports Chest pain stuttering over several days. This am

More information

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding Get With The Guidelines -Stroke is the American Heart Association s collaborative performance improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized with

More information

Disclosures 1/25/2018. Mission: Quality Can Mission Lifeline Help Your Performance Improvement Program? None

Disclosures 1/25/2018. Mission: Quality Can Mission Lifeline Help Your Performance Improvement Program? None Mission: Quality Can Mission Lifeline Help Your Performance Improvement Program? Jeremy T Cushman, MD MS EMT-P FACEP FAEMS Associate Professor of Emergency Medicine and Public Health Sciences Chief, Division

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

Suicide Prevention Gatekeeper Training Results (2009)

Suicide Prevention Gatekeeper Training Results (2009) Suicide Prevention Gatekeeper Training Results (2009) The Ohio State University Campus Suicide Prevention Program suicideprevention.osu.edu Mission: To develop a comprehensive, effective, culturally responsive,

More information

Do Not Cite. Draft for Work Group Review.

Do Not Cite. Draft for Work Group Review. Defect Free Acute Inpatient Ischemic Stroke Measure Bundle Measure Description Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke OR transient ischemic attack who were admitted

More information

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer: When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation

More information

Diagnosis and Management of Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

NCDR Outpatient Registries v1.5 Data Dictionary - Full Specifications

NCDR Outpatient Registries v1.5 Data Dictionary - Full Specifications 1. General Information Seq. #: 1500 Name: Medical Record Number (MRN) Coding Instructions: Indicate the patient's medical record number as assigned by the medical practice. (none) Patient_MRN Illegal Text

More information

NCDR AFib Ablation Registry v1.0 Atrial Fibrillation (AF) Ablation Interventional Registry

NCDR AFib Ablation Registry v1.0 Atrial Fibrillation (AF) Ablation Interventional Registry A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Sex 2060 : O Male O Female Patient Zip Code

More information

2010 ACLS Guidelines. Primary goals of therapy for patients

2010 ACLS Guidelines. Primary goals of therapy for patients 2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in

More information

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

convey the clinical quality measure's title, number, owner/developer and contact

convey the clinical quality measure's title, number, owner/developer and contact CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical

More information

Effective for Patient Discharges July 01, , American College of Cardiology Foundation 7/1/2017 Page 1 of 130

Effective for Patient Discharges July 01, , American College of Cardiology Foundation 7/1/2017 Page 1 of 130 A. Demographics Seq. #: 2000 Name: Last Name Coding Instructions: Indicate the patient's last name. Hyphenated names should be recorded with a hyphen. Target Value: The value on arrival at this facility

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

How to give thrombolysis in acute myocardial infarction

How to give thrombolysis in acute myocardial infarction Page 1 of 6 How to give thrombolysis in acute myocardial infarction Original article: Michael Tam In the major urban hospitals, there will be little place for thrombolysis in acute STEMI (STelevation myocardial

More information

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Learning Objectives. Epidemiology of Acute Coronary Syndrome Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

More information

Name: Phone #: Address: Cell Phone #: Address: I d like to participate in:

Name: Phone #: Address: Cell Phone #:  Address: I d like to participate in: Strong Women and Strong Women Advance Program 12-Week Participant Registration Form January 8-April 2*, 2018 *Good Friday Week Schedule Changes: Strong Classes class will meet Monday (3/26) instead of

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

Downloaded from:

Downloaded from: Annemans, L; Danchin, N; Van de Werf, F; Pocock, S; Licour, M; Medina, J; Bueno, H (2016) Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis

More information

IN THIS ISSUE. Executive Communication: Southeastern RACE Region. Regional EMS Spotlight: Brunswick EMS

IN THIS ISSUE. Executive Communication: Southeastern RACE Region. Regional EMS Spotlight: Brunswick EMS STEMI news NHRMC Heart Center Update on STEMI Systems of Care in Southeastern North Carolina SPRING 2012 WELCOME to the inaugural issue of the New Hanover Regional Medical Center STEMI Newsletter. New

More information